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Background
Humoral immune responses are often the hallmark of
efficient vaccines. The recent RV144 vaccine trial has
turned attention to the stimulation of humoral immune
response as a potential mode of action for HIV vaccines.
Therefore, detailed monitoring of antibody reactivities in
patient specimens before and after vaccination is crucial.
The determination of these reactivities on a sub-protein
level provides information on the site of antigen/antibody
interaction. In contrast to assays relying on whole anti-
gens such as ELISA, peptide microarrays are efficient
tools to deliver such information. Besides, complex pep-
tide libraries can cover HIV sequence diversity, a special
challenge provided by this virus.
Materials and methods
Based on the sequence database of LANL a complex pep-
tide library of more than 6500 peptides was generated.
The peptides were synthesized and printed onto glass
slides.
Initial incubations with serum samples of non-human
primates from vaccination studies were performed and
evaluated.
Results
The peptides span the immunogenic regions of the HIV
proteome including full-length ENV, NEF and fractions of
GAG, POL, TAT, REV and VIF and allow an overall cov-
erage above 50 % of all HIV sequences. Each clade (A, B,
C, D, G, CRF1 and CRF2) is represented by at least one
sequence. Additional sequences were added to improve
coverage.
Experimental data for serum samples from vaccination
trials allow the identification of antibody reactivities fol-
lowing vaccination. The representation of different
clades allows a detailed evaluation of specificity for the
raised antibodies.
Conclusion
High-density high-content peptide microarrays can tackle
the tremendous sequence diversity of HIV and deliver
information on clade-specific antibody response. This
enables monitoring of humoral immune response in HIV
patients independent of geographical origin and to study
a broad range of different vaccines. The results can shed
light on the underlying protective mechanisms of
vaccinations.
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